Segeberger Kliniken

Six Versus Twelve Months Clopidogrel Therapy after Drug-Eluting Stenting in Patients with Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis (2016) Lohaus R, Michel J, Mayer K, Lahmann AL, Byrne RA, Wolk A, Ten Berg JM, et al. Journal article Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials (2016) Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, et al. Journal article Fraktionelle Flussreserve in der Diagnostik der koronaren Herzerkrankung: Klinische Bedeutung, Durchführung und Interpretation (2016) Möllmann H, Rudolph T, Rieber J, Eggebrecht H, Richardt G, Schmitz T, Werner N, Achenbach S Journal article Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R) (2016) Nef H, Wiebe J, Achenbach S, Muenzel T, Naber C, Richardt G, Mehilli J, et al. Journal article ISAR-SAFE: A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting (2015) Schulz-Schuepke S, Byrne RA, Ten Berg JM, Neumann FJ, Han Y, Adriaenssens T, Toelg R, et al. Journal article Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age (2014) Ndrepepa G, Neumann FJ, Schulz S, Fusaro M, Cassese S, Byrne RA, Richardt G, et al. Journal article Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease (2014) Ndrepepa G, Neumann FJ, Cassese S, Fusaro M, Ott I, Schulz S, Hoppmann P, et al. Journal article Comparison of prasugrel and bivalirudin vs clopidogrel and heparin in patients with St-segment elevation myocardial infarction: Design and rationale of the bavarian reperfusion alternatives evaluation (brave) 4 trial (2014) Schulz S, Richardt G, Laugwitz KL, Mehran R, Gershlick AH, Morath T, Mayer K, et al. Journal article Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes (2014) Ndrepepa G, Schulz S, Neumann FJ, Laugwitz KL, Richardt G, Byrne RA, Poehler A, et al. Journal article Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction (2014) Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, et al. Journal article